Presentation is loading. Please wait.

Presentation is loading. Please wait.

Swallowing Outcomes in Head & Neck Cancer

Similar presentations


Presentation on theme: "Swallowing Outcomes in Head & Neck Cancer"— Presentation transcript:

1 Swallowing Outcomes in Head & Neck Cancer
Jo Patterson Macmillan Speech & Language Therapist/Research Fellow

2 Swallowing Outcomes Critique assessments Collector’s perspective
Patient rated outcomes Clinical scales Clinical indicators

3 Patient reported outcomes
SWAL-QOL / SWAL-CARE M.D.Anderson Dysphagia Inventory

4 SWAL-QOL (McHorney 2002) Devised from patient focus group (N=549, 14.5% head & neck cancer) Good correlation with UWQOL (Lovell 2005) Moderately related to pathophysiology

5 Measurement tool SWAL-QOL 2002 (44 items, 11 domains)
general burden* (fatigue) food selection* (sleep) eating duration (communication) eating desire fear of eating mental health* social function* symptom frequency

6 Data Sample N=65 (49 males; 16 females) Age 32-80y mean 60y
Oral (31) oropharyngeal (30) NPC (4) T1-2 (35) T3-4 (30) Surgery (10) surgery & radiotherapy (36) chemoradiotherapy (13) radiotherapy (6) 35 completed pre & post SWAL-QOL Analysed using ANOVA

7 Pre-treatment

8 6 months post treatment

9 Collector’s perspective
Author’s report 14 mins to complete – much longer needed Difficult to analyse – many components Good sections – includes symptoms Not to be done cross-sectional

10 M.D. Anderson Dysphagia Inventory (Chen 2001)
20 items (sub-groups emotion, physical, function) Devised from professionals (SALTs & Surgeons) Good reliability Correlates with UWQOL No association with aspiration (Gillespie 2005) Used as outcome for swallowing exercises (Kulbersh 2006)

11 MDADI pre & post CRT Demographics
Tx Orophx 6 9 7 24 - Hypophx 2 3 Larynx 23 11 4 U/k 1° Total = 116

12 Comparison pre & post

13 Collector’s perspective
10 mins to complete ‘no opinion’ poses difficulties Difficult to use on someone without swallowing difficulties Difficult to use on NBM patients One item complex double negative

14 Quality of Life Questionnaires
University of Washington QOL Scales DAHNO Correlates with VFSS, HADS, MDADI, SWAL-QOL, TOMS Short, quick to complete Wide research base Difficult to find out how it was devised Reproducible, reliable & valid Originally intended for surgical group Additions of taste, saliva, mood, anxiety Speech & saliva difficult for people to answer

15 Pre-treatment priorities

16 Clinical Scales Performance Status Scales (List ’90)
Therapy Outcome Measures (TOMS) FIGS

17 Performance Status Scales (List 1990)
Developed by surgeons, oncologists & SALTs Purpose; research & clinical Normalcy of diet, eating in public, communication Rated by ‘health professionals’ High reliability Correlates with QOL Included in DAHNO dataset

18 Diet scale pre vs. 3 months post Chemoradiotherapy

19 Collectors perspective
Quick Can be done by other staff Some diets difficult to grade Can give false positive results Gradations ?equal Large literature base for comparison ?swallowing outcome

20 Therapy Outcome Measures (Enderby ’77)
10 core patients specific scales ‘Laryngectomy’ only scale specific to H&NC Scales on voice, dysarthria, phonology & dysphagia Pilot study Radford et al 2003 Correlates with UWQOL scales ?modification for H&NC

21 Functional Intraoral Glasgow Scale (FIGS)(Goldie 2006)
Originated Canniesburn Hospital 3 scales – chew, swallow & speech Total score of all 3 items

22 Clinical Indicators Aspiration / penetration Residue
Swallowing efficiency Feeding tube dependency

23 Aspiration / Penetration
H&NC literature focuses on aspiration Penetration / aspiration scale (Rosenbek) Increases reliability of findings One score Requires instrumental assessment ?meaningful to clinical picture / patient

24 % Aspiration Post CRT % aspiration

25 % Aspiration pneumonia

26 Swallowing Efficiency
Residue Oropharyngeal swallowing efficiency Water swallow test

27 Mean time to swallow 100mLs water pre-treatment

28 Tube feeding NPC T.Base U/k 1° Total No Peg 4 12 11 27(40%) 0-4week -
5 5(12%) 4-12wks 1 3(7%) 12-24wks 7 9(22%) 24-52wks 2 17(14%) >52wks 6 7(17%) 10 42 16 68

29 DAHNO Was the patient seen for pre treatment SALT assessment?
PSS Normalcy of Diet Weight Type & timing of nutritional support

30 Summary Choice of measures One-dimensional, cross-sectional misleading
Needs to be longitudinal, set time points Simple / collectable What questions to ask of the data It will require dedicated time ?interventions DAHNO


Download ppt "Swallowing Outcomes in Head & Neck Cancer"

Similar presentations


Ads by Google